Sign Up Today and Learn More About Gate Bioscience Stock
Invest in or calculate the value of your shares in Gate Bioscience or other pre-IPO companies through EquityZen's platform.
Gate Bioscience Stock
Gate Bioscience is a biotechnology company that specializes in a small molecule modality to treat biology’s intractable diseases.
About Gate Bioscience Stock
Founded
2021
Headquarters
Brisbane, CA, US
Industries
Sales and Marketing, Design, Supply Chain and Logistics
Gate Bioscience Press Mentions
Stay in the know about the latest news on Gate Bioscience
Gate closes $65m series B to push molecular gate drugs into the clinic
thepharmaletter • Nov 15, 2025
Mangoceuticals says co has no direct contractual relationship with Eli Lilly or Novo Nordisk
marketscreener • Nov 14, 2025
Novo Nordisk, Eli Lilly Say No Partnership on Weight-loss Drugs with Mangoceuticals
marketscreener • Nov 14, 2025
Gate Bioscience Announces $65 Million Oversubscribed Series B Financing to Advance Oral Molecular Gate Medicines into the Clinic
globenewswire • Nov 14, 2025
Gate Bioscience Announces $65 Million Oversubscribed Series B Financing to Advance Oral Molecular Gate Medicines into the Clinic
vcaonline • Nov 14, 2025
Gate Bioscience Management
Leadership team at Gate Bioscience
Board Member
Vineeta Agarwala
Board Member
Vanessa Carle
Join now and verify your accreditation status to gain access to:
- Gate Bioscience Current Valuation
- Gate Bioscience Stock Price
- Gate Bioscience Management
- Available deals in Gate Bioscience and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Gate Bioscience Cap Table and Funding History by Share Class and Liquidity Preferences
- Gate Bioscience Revenue and Financials
- Gate Bioscience Highlights
- Gate Bioscience Business Model
- Gate Bioscience Risk Factors
- Gate Bioscience Research Report from SACRA Research
Trading Gate Bioscience Stock
How to invest in Gate Bioscience stock?
Accredited investors can buy pre-IPO stock in companies like Gate Bioscience through EquityZen funds. These investments are made available by existing Gate Bioscience shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Gate Bioscience stock?
Shareholders can sell their Gate Bioscience stock through EquityZen's private company marketplace. EquityZen's network includes over 400K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 49K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."